Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Urol Oncol. 2011 Nov 27;30(1):102–108. doi: 10.1016/j.urolonc.2011.09.001

Table 1.

Summary of multivariate statistically significant associations between covariates and outcomes in the UCLA Men’s Health Study.

Variables PF EWB Pain PCS MCS MHI-5 UF UB SF SB BF BB Regret Anxiety SDS PEPPI
Advancing Age +34 36 36

Race

 Hispanic 41 41 26,27,31 30,31 41 41 33,41 26,27,33,41 27,33,41 34 41
 African American 33 33 33 34 +27,31
 Other 26,33,41 41 33,41 33 34

Partnership Status

 Partnered +33 +33 +31 +31,33 +33 +31,41

Stage

 Regional 31
 Metastatic 41 31 31 31,41

Gleason Score

 ≥6 28 28 28

Education

 < HS 33 +28 32

Comorbidity

 Charlson >1 33 26

Treatment

 Surgery 26,33 26,33 33 33
 Radiation 41 +31
 Hormone Therapy 33 +31 33 33 +41

Spirituality

 Peace/Meaning +41 +40 +40,41 +40,41 +41 +40,41 +40,41 +40,41 +41 +41
 High +41 +41 +41 +30 +40 +41 +41 +40,41 +34 +41 +41

Time since treatment

 Time (continuous) +33 33 +33

IMPACT status

 Waitlisted 14 14

Abbreviations: Physical functioning (PF); Emotional well being (EWB); Physical composite score (PCS); Mental composite score (MCS); Urinary function (UF); Urinary bother (UB); Sexual function (SF); Sexual bother (SB); Bowel function (BF); Bowel bother (BB); Symptom distress scale (SDS); and Perceived Efficacy in Patient–Physician Interaction (PEPPI).

Referent Groups: Race (white); Partnership status (unpartnered); Stage (localized); Gleason score (<6); Education (college education); Comorbidity (Charlson score <1); Treatment (watchful waiting); Spirituality (low); and IMPACT status (enrolled).

Multivariate outcomes: + denotes statistically significant improved outcomes (p<0.05); − denotes statistically significant worse outcomes (p<0.05). Numbers refer to corresponding references in the manuscript.